VECTUS BIOSYSTEMS LIMITED - Announcements

Market Cap $4.097M Add to my watchlist

Healthcare Biotechnology

Vectus Biosystems Limited is an Australia-based drug discovery and development company.... Vectus Biosystems Limited is an Australia-based drug discovery and development company. The Company focuses on medical research and development. It is engaged in developing a treatment for fibrosis and high blood pressure, which includes the treatment for diseases in the fibrotic market, namely heart, kidney, and liver diseases. Its compound, VB0004, focuses on treating the hardening of functional tissue and high blood pressure. It also focuses on developing candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis (NASH) as well as pulmonary fibrotic diseases. The Company has also developed technology focused at improving the speed and accuracy of measuring the amount of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in samples tested in laboratories. Accugen is a platform, developed by its wholly owned subsidiary, Accugen Pty Limited, comprising of reagents, and software that quantitate polymerase chain reaction (qPCR) reactions.More

Announcements

Filter Results

All Price Sensitive Only

VBS	Quarterly Activities Report & Appendix 4C	PRICE SENSITIVE	29/10/21	443.45KB	Share
VBS	Corporate Governance Statement & Appendix 4G		25/10/21	598.59KB	Share
VBS	Annual Report to shareholders		25/10/21	4.69MB	Share
VBS	Response to ASX Price and Volume Query	PRICE SENSITIVE	19/10/21	341.37KB	Share
VBS	Appendix 2A - Issue of Shares		07/10/21	638.79KB	Share
VBS	Broker Briefing Investor Webinar		07/09/21	128.2KB	Share
VBS	Update on Phase I Human Trial	PRICE SENSITIVE	07/09/21	130.14KB	Share
VBS	Full Year Statutory Accounts		31/08/21	2.27MB	Share
VBS	Preliminary Final Report - Appendix 4E	PRICE SENSITIVE	31/08/21	99.81KB	Share
VBS	Progress Presentation		30/08/21	2.45MB	Share
VBS	Successful Completion of First Group in Phase I Human Trial	PRICE SENSITIVE	23/08/21	181.4KB	Share
VBS	Quarterly Activities Report & Appendix 4C	PRICE SENSITIVE	30/07/21	462.01KB	Share
VBS	Approval Received for Phase I Trial in Australia	PRICE SENSITIVE	17/06/21	146.76KB	Share
VBS	Appendix 3G - Issue of Options under EIP		27/05/21	548.17KB	Share
VBS	Quarterly Activities Report & Appendix 4C	PRICE SENSITIVE	29/04/21	442.84KB	Share
VBS	Half Yearly Report and Appendix 4D	PRICE SENSITIVE	26/02/21	1.13MB	Share
VBS	Quarterly Activities Report & Appendix 4C	PRICE SENSITIVE	29/01/21	437.13KB	Share
VBS	Issue of Placement Shares - Appendix 2A		07/12/20	741.35KB	Share
VBS	Results of Annual General Meeting		30/11/20	361.32KB	Share
VBS	Chairman & CEO Address to Shareholders		30/11/20	4.97MB	Share
VBS	Proposed issue of Securities - VBS	PRICE SENSITIVE	20/11/20	25.9KB	Share
VBS	Vectus completes $7 million placement	PRICE SENSITIVE	20/11/20	377.25KB	Share
VBS	Trading Halt	PRICE SENSITIVE	19/11/20	167.5KB	Share
VBS	Notice of Annual General Meeting / Proxy Form		02/11/20	837.76KB	Share
VBS	Quarterly Activities Report & Appendix 4C	PRICE SENSITIVE	30/10/20	532.69KB	Share
VBS	Corporate Governance Statement & Appendix 4G		29/10/20	1002.23KB	Share
VBS	Annual Report to shareholders		29/10/20	2.38MB	Share
VBS	VBS - Date of 2020 AGM		16/10/20	213.47KB	Share
VBS	Issue of Shares - Appendix 2A		29/09/20	682.15KB	Share
VBS	Full Year Statutory Accounts		31/08/20	5.55MB	Share
VBS	Preliminary Final Report - Appendix 4E	PRICE SENSITIVE	31/08/20	108.86KB	Share
VBS	Becoming a substantial holder		19/08/20	259.84KB	Share
VBS	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	31/07/20	532.49KB	Share
VBS	Issue of Options		27/07/20	884.63KB	Share
VBS	Appendix 4C - Quarterly Report		09/06/20	407.79KB	Share
VBS	Appendix 4C - Quarterly Report	PRICE SENSITIVE	30/04/20	549.08KB	Share
VBS	Publication on Reversal of Kidney Fibrotic Damage		10/03/20	241.71KB	Share
VBS	Half Year Report	PRICE SENSITIVE	28/02/20	1.1MB	Share
VBS	Appendix 4C - Quarterly Report	PRICE SENSITIVE	31/01/20	424.45KB	Share
VBS	Change of Director's Interest Notice - KD		21/01/20	354.28KB	Share
VBS	Appendix 3B Issue of Shares		20/01/20	536.02KB	Share
VBS	Change of Director's Interest Notice - RS		24/12/19	253.18KB	Share
VBS	Change of Director's Interest Notice - MS		24/12/19	262.29KB	Share
VBS	Appendix 3B - Issue of Convertible Notes		24/12/19	1.14MB	Share
VBS	Results of Annual General Meeting		22/11/19	236.61KB	Share
VBS	CEO Presentation at AGM		22/11/19	3.19MB	Share
VBS	Chairman's Address to AGM		22/11/19	147.98KB	Share
VBS	Director Loan Security		20/11/19	131.59KB	Share
VBS	Response to ASX Appendix 3Y Query		18/11/19	293.37KB	Share
VBS	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/19	461.91KB	Share
VBS	Change of Director's Interest Notice - PB		28/10/19	256.94KB	Share
VBS	Notice of Annual General Meeting/Proxy Form		21/10/19	876.9KB	Share
VBS	Publication of preclinical data in model of cardiac fibrosis		08/10/19	226.13KB	Share
VBS	Appendix 3B - issue of shares & options		03/10/19	797.06KB	Share
VBS	2019 Corporate Governance Statement & Appendix 4G		30/09/19	1.07MB	Share
VBS	Annual Report to Shareholders		30/09/19	4.8MB	Share
VBS	Convertible Notes Appendix 3B and Cleansing Notice		30/09/19	1.13MB	Share
VBS	Response to ASX Price Query	PRICE SENSITIVE	24/09/19	529.24KB	Share
VBS	Convertible Note Issue	PRICE SENSITIVE	17/09/19	356.57KB	Share
VBS	Preliminary Final Report Appendix 4E	PRICE SENSITIVE	30/08/19	440.04KB	Share
VBS	Vectus Investor Presentation		20/08/19	4MB	Share
VBS	Response to Appendix 4C Query	PRICE SENSITIVE	09/08/19	1.4MB	Share
VBS	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/19	449.39KB	Share
VBS	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/19	451.86KB	Share
VBS	Half Year Report and Appendix 4D	PRICE SENSITIVE	28/02/19	1.03MB	Share
VBS	Response to ASX Appendix 4C Query	PRICE SENSITIVE	22/02/19	671.19KB	Share
VBS	Appendix 4C - Quarterly Report	PRICE SENSITIVE	31/01/19	453.32KB	Share
VBS	Results of Meeting		14/11/18	221.54KB	Share
VBS	CEO's Address to Shareholders	PRICE SENSITIVE	14/11/18	2.79MB	Share
VBS	Chairman's Address to Shareholders	PRICE SENSITIVE	14/11/18	219.49KB	Share
VBS	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/18	405.14KB	Share
VBS	Notice of Annual General Meeting and Proxy Form		12/10/18	342.38KB	Share
VBS	2018 Corporate Governance Statement and Appendix 4G		12/10/18	1.04MB	Share
VBS	Annual Report to shareholders		12/10/18	12.19MB	Share
VBS	Appendix 3B - Issue under EIP		12/10/18	800.69KB	Share
VBS	Full Year Statutory Accounts		28/09/18	1.82MB	Share
VBS	Director Retirement & Final Director's Interest Notice - GM		31/08/18	461.42KB	Share
VBS	Preliminary Final Report	PRICE SENSITIVE	31/08/18	423.34KB	Share
VBS	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/18	445.59KB	Share
VBS	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/18	506.16KB	Share
VBS	Appendix 3B End Escrow and Issue under EIP		08/03/18	814.97KB	Share
VBS	Half Year Report and Appendix 4D	PRICE SENSITIVE	28/02/18	1.6MB	Share
VBS	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/18	452.65KB	Share
VBS	Release of Restricted Securities from Escrow		24/01/18	266.75KB	Share
VBS	Results of Meeting		16/11/17	169.39KB	Share
VBS	Chairman and CEO Addresses to AGM		16/11/17	5.73MB	Share
VBS	Appendix 4C - Quarterly	PRICE SENSITIVE	31/10/17	400.84KB	Share
VBS	Successful Pre-Clinical Trial and Granting of Key Patent	PRICE SENSITIVE	20/10/17	200.02KB	Share
VBS	Notice of Annual General Meeting/Proxy Form		16/10/17	340.65KB	Share
VBS	2017 Corporate Governance Statement		13/10/17	1.03MB	Share
VBS	Annual Report to shareholders		13/10/17	9.63MB	Share
VBS	Full Year Statutory Accounts		28/09/17	1.75MB	Share
VBS	Preliminary Final Report	PRICE SENSITIVE	31/08/17	434.41KB	Share
VBS	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/17	430.66KB	Share
VBS	Appendix 3B - Issue of Options		05/06/17	785.6KB	Share
VBS	Appendix 4C - Quarterly Report and Update	PRICE SENSITIVE	28/04/17	324.42KB	Share
VBS	Half Yearly Report and Appendix 4D	PRICE SENSITIVE	28/02/17	1.31MB	Share
VBS	Response to ASX Appendix 4C Query	PRICE SENSITIVE	13/02/17	712.51KB	Share
VBS	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/17	402.78KB	Share
VBS	Appendix 3B Issue of EIP Shares and Options		27/01/17	854.34KB	Share

VBS Quarterly Activities Report & Appendix 4C
29/10/21	PRICE SENSITIVE	443.45KB	Share
VBS Corporate Governance Statement & Appendix 4G
25/10/21		598.59KB	Share
VBS Annual Report to shareholders
25/10/21		4.69MB	Share
VBS Response to ASX Price and Volume Query
19/10/21	PRICE SENSITIVE	341.37KB	Share
VBS Appendix 2A - Issue of Shares
07/10/21		638.79KB	Share
VBS Broker Briefing Investor Webinar
07/09/21		128.2KB	Share
VBS Update on Phase I Human Trial
07/09/21	PRICE SENSITIVE	130.14KB	Share
VBS Full Year Statutory Accounts
31/08/21		2.27MB	Share
VBS Preliminary Final Report - Appendix 4E
31/08/21	PRICE SENSITIVE	99.81KB	Share
VBS Progress Presentation
30/08/21		2.45MB	Share
VBS Successful Completion of First Group in Phase I Human Trial
23/08/21	PRICE SENSITIVE	181.4KB	Share
VBS Quarterly Activities Report & Appendix 4C
30/07/21	PRICE SENSITIVE	462.01KB	Share
VBS Approval Received for Phase I Trial in Australia
17/06/21	PRICE SENSITIVE	146.76KB	Share
VBS Appendix 3G - Issue of Options under EIP
27/05/21		548.17KB	Share
VBS Quarterly Activities Report & Appendix 4C
29/04/21	PRICE SENSITIVE	442.84KB	Share
VBS Half Yearly Report and Appendix 4D
26/02/21	PRICE SENSITIVE	1.13MB	Share
VBS Quarterly Activities Report & Appendix 4C
29/01/21	PRICE SENSITIVE	437.13KB	Share
VBS Issue of Placement Shares - Appendix 2A
07/12/20		741.35KB	Share
VBS Results of Annual General Meeting
30/11/20		361.32KB	Share
VBS Chairman & CEO Address to Shareholders
30/11/20		4.97MB	Share
VBS Proposed issue of Securities - VBS
20/11/20	PRICE SENSITIVE	25.9KB	Share
VBS Vectus completes $7 million placement
20/11/20	PRICE SENSITIVE	377.25KB	Share
VBS Trading Halt
19/11/20	PRICE SENSITIVE	167.5KB	Share
VBS Notice of Annual General Meeting / Proxy Form
02/11/20		837.76KB	Share
VBS Quarterly Activities Report & Appendix 4C
30/10/20	PRICE SENSITIVE	532.69KB	Share
VBS Corporate Governance Statement & Appendix 4G
29/10/20		1002.23KB	Share
VBS Annual Report to shareholders
29/10/20		2.38MB	Share
VBS VBS - Date of 2020 AGM
16/10/20		213.47KB	Share
VBS Issue of Shares - Appendix 2A
29/09/20		682.15KB	Share
VBS Full Year Statutory Accounts
31/08/20		5.55MB	Share
VBS Preliminary Final Report - Appendix 4E
31/08/20	PRICE SENSITIVE	108.86KB	Share
VBS Becoming a substantial holder
19/08/20		259.84KB	Share
VBS Quarterly Activities Report and Appendix 4C
31/07/20	PRICE SENSITIVE	532.49KB	Share
VBS Issue of Options
27/07/20		884.63KB	Share
VBS Appendix 4C - Quarterly Report
09/06/20		407.79KB	Share
VBS Appendix 4C - Quarterly Report
30/04/20	PRICE SENSITIVE	549.08KB	Share
VBS Publication on Reversal of Kidney Fibrotic Damage
10/03/20		241.71KB	Share
VBS Half Year Report
28/02/20	PRICE SENSITIVE	1.1MB	Share
VBS Appendix 4C - Quarterly Report
31/01/20	PRICE SENSITIVE	424.45KB	Share
VBS Change of Director's Interest Notice - KD
21/01/20		354.28KB	Share
VBS Appendix 3B Issue of Shares
20/01/20		536.02KB	Share
VBS Change of Director's Interest Notice - RS
24/12/19		253.18KB	Share
VBS Change of Director's Interest Notice - MS
24/12/19		262.29KB	Share
VBS Appendix 3B - Issue of Convertible Notes
24/12/19		1.14MB	Share
VBS Results of Annual General Meeting
22/11/19		236.61KB	Share
VBS CEO Presentation at AGM
22/11/19		3.19MB	Share
VBS Chairman's Address to AGM
22/11/19		147.98KB	Share
VBS Director Loan Security
20/11/19		131.59KB	Share
VBS Response to ASX Appendix 3Y Query
18/11/19		293.37KB	Share
VBS Appendix 4C - quarterly
31/10/19	PRICE SENSITIVE	461.91KB	Share
VBS Change of Director's Interest Notice - PB
28/10/19		256.94KB	Share
VBS Notice of Annual General Meeting/Proxy Form
21/10/19		876.9KB	Share
VBS Publication of preclinical data in model of cardiac fibrosis
08/10/19		226.13KB	Share
VBS Appendix 3B - issue of shares & options
03/10/19		797.06KB	Share
VBS 2019 Corporate Governance Statement & Appendix 4G
30/09/19		1.07MB	Share
VBS Annual Report to Shareholders
30/09/19		4.8MB	Share
VBS Convertible Notes Appendix 3B and Cleansing Notice
30/09/19		1.13MB	Share
VBS Response to ASX Price Query
24/09/19	PRICE SENSITIVE	529.24KB	Share
VBS Convertible Note Issue
17/09/19	PRICE SENSITIVE	356.57KB	Share
VBS Preliminary Final Report Appendix 4E
30/08/19	PRICE SENSITIVE	440.04KB	Share
VBS Vectus Investor Presentation
20/08/19		4MB	Share
VBS Response to Appendix 4C Query
09/08/19	PRICE SENSITIVE	1.4MB	Share
VBS Appendix 4C - quarterly
31/07/19	PRICE SENSITIVE	449.39KB	Share
VBS Appendix 4C - quarterly
30/04/19	PRICE SENSITIVE	451.86KB	Share
VBS Half Year Report and Appendix 4D
28/02/19	PRICE SENSITIVE	1.03MB	Share
VBS Response to ASX Appendix 4C Query
22/02/19	PRICE SENSITIVE	671.19KB	Share
VBS Appendix 4C - Quarterly Report
31/01/19	PRICE SENSITIVE	453.32KB	Share
VBS Results of Meeting
14/11/18		221.54KB	Share
VBS CEO's Address to Shareholders
14/11/18	PRICE SENSITIVE	2.79MB	Share
VBS Chairman's Address to Shareholders
14/11/18	PRICE SENSITIVE	219.49KB	Share
VBS Appendix 4C - quarterly
31/10/18	PRICE SENSITIVE	405.14KB	Share
VBS Notice of Annual General Meeting and Proxy Form
12/10/18		342.38KB	Share
VBS 2018 Corporate Governance Statement and Appendix 4G
12/10/18		1.04MB	Share
VBS Annual Report to shareholders
12/10/18		12.19MB	Share
VBS Appendix 3B - Issue under EIP
12/10/18		800.69KB	Share
VBS Full Year Statutory Accounts
28/09/18		1.82MB	Share
VBS Director Retirement & Final Director's Interest Notice - GM
31/08/18		461.42KB	Share
VBS Preliminary Final Report
31/08/18	PRICE SENSITIVE	423.34KB	Share
VBS Appendix 4C - quarterly
31/07/18	PRICE SENSITIVE	445.59KB	Share
VBS Appendix 4C - quarterly
30/04/18	PRICE SENSITIVE	506.16KB	Share
VBS Appendix 3B End Escrow and Issue under EIP
08/03/18		814.97KB	Share
VBS Half Year Report and Appendix 4D
28/02/18	PRICE SENSITIVE	1.6MB	Share
VBS Appendix 4C - quarterly
31/01/18	PRICE SENSITIVE	452.65KB	Share
VBS Release of Restricted Securities from Escrow
24/01/18		266.75KB	Share
VBS Results of Meeting
16/11/17		169.39KB	Share
VBS Chairman and CEO Addresses to AGM
16/11/17		5.73MB	Share
VBS Appendix 4C - Quarterly
31/10/17	PRICE SENSITIVE	400.84KB	Share
VBS Successful Pre-Clinical Trial and Granting of Key Patent
20/10/17	PRICE SENSITIVE	200.02KB	Share
VBS Notice of Annual General Meeting/Proxy Form
16/10/17		340.65KB	Share
VBS 2017 Corporate Governance Statement
13/10/17		1.03MB	Share
VBS Annual Report to shareholders
13/10/17		9.63MB	Share
VBS Full Year Statutory Accounts
28/09/17		1.75MB	Share
VBS Preliminary Final Report
31/08/17	PRICE SENSITIVE	434.41KB	Share
VBS Appendix 4C - quarterly
31/07/17	PRICE SENSITIVE	430.66KB	Share
VBS Appendix 3B - Issue of Options
05/06/17		785.6KB	Share
VBS Appendix 4C - Quarterly Report and Update
28/04/17	PRICE SENSITIVE	324.42KB	Share
VBS Half Yearly Report and Appendix 4D
28/02/17	PRICE SENSITIVE	1.31MB	Share
VBS Response to ASX Appendix 4C Query
13/02/17	PRICE SENSITIVE	712.51KB	Share
VBS Appendix 4C - quarterly
30/01/17	PRICE SENSITIVE	402.78KB	Share
VBS Appendix 3B Issue of EIP Shares and Options
27/01/17		854.34KB	Share

REFRESH

First 2

(20min delay)
Last 7.7¢		Change 0.000(0.00%)		Mkt cap ! $4.097M

Open	High	Low	Value	Volume
7.7¢	7.7¢	7.7¢	$21.63K	281K

Buyers (Bids)

No.	Vol.	Price($)
2	60732	7.7¢

Sellers (Offers)

Price($)	Vol.	No.
9.2¢	7601	1

View Market Depth

No.	Vol.	Price($)
2	60732	0.077
3	272500	0.076
1	40000	0.075
1	75000	0.072
1	10000	0.052

Price($)	Vol.	No.
0.092	7601	1
0.095	22897	1
0.120	2700	1
0.000	0	0
0.000	0	0

Last trade - 15.47pm 28/06/2024 (20 minute delay)

VBS (ASX) Chart

VECTUS BIOSYSTEMS LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories